Kenvue Inc. $KVUE Shares Sold by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D reduced its holdings in Kenvue Inc. (NYSE:KVUE) by 0.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 649,502 shares of the company’s stock after selling 1,826 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Kenvue were worth $13,594,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the business. Carrera Capital Advisors acquired a new stake in shares of Kenvue in the 2nd quarter valued at approximately $230,000. AlphaQuest LLC raised its holdings in Kenvue by 276.0% during the second quarter. AlphaQuest LLC now owns 12,086 shares of the company’s stock worth $253,000 after purchasing an additional 8,872 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its holdings in Kenvue by 1.7% during the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,861,654 shares of the company’s stock worth $101,754,000 after purchasing an additional 79,724 shares during the last quarter. West Michigan Advisors LLC acquired a new position in Kenvue during the second quarter worth $264,000. Finally, Caitong International Asset Management Co. Ltd increased its position in Kenvue by 675,800.0% during the second quarter. Caitong International Asset Management Co. Ltd now owns 13,518 shares of the company’s stock worth $283,000 after buying an additional 13,516 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on KVUE. Canaccord Genuity Group lowered their price objective on Kenvue from $29.00 to $26.00 and set a “buy” rating for the company in a research report on Friday, August 8th. Royal Bank Of Canada reduced their price objective on Kenvue from $24.00 to $22.00 and set a “sector perform” rating on the stock in a research note on Friday, August 8th. Rothschild Redb raised Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, September 26th. JPMorgan Chase & Co. lowered their target price on Kenvue from $24.00 to $21.00 and set an “overweight” rating for the company in a report on Friday, October 10th. Finally, Citigroup cut their price objective on Kenvue from $20.00 to $17.00 and set a “neutral” rating for the company in a research report on Thursday, October 9th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $20.75.

Kenvue Trading Down 0.6%

NYSE:KVUE opened at $15.00 on Friday. The stock’s 50 day moving average price is $17.91 and its 200 day moving average price is $20.79. Kenvue Inc. has a 52 week low of $14.05 and a 52 week high of $25.17. The company has a market capitalization of $28.78 billion, a P/E ratio of 20.26, a P/E/G ratio of 2.16 and a beta of 0.72. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.01. The business had revenue of $3.84 billion during the quarter, compared to analysts’ expectations of $3.94 billion. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The firm’s revenue was down 4.0% on a year-over-year basis. During the same quarter last year, the company earned $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were paid a dividend of $0.2075 per share. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.83 dividend on an annualized basis and a yield of 5.5%. The ex-dividend date was Wednesday, August 13th. Kenvue’s dividend payout ratio is 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.